Beck Mack & Oliver LLC Johnson & Johnson Transaction History

Beck Mack & Oliver LLC

$4.44 Billion
Q3 2024

A detailed history of Beck Mack & Oliver LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 250,500 shares of JNJ stock, worth $38.7 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

250,500

Previous 254,605 1.61%

Holding current value

$38.7 Million

Previous $37.2 Million 9.09%

% of portfolio

0.91%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $597,195 - $687,094	-4,105 Reduced 1.61%	250,500 $40.6 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $1.71 Million - $1.87 Million	-11,837 Reduced 4.44%	254,605 $37.2 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $1.08 Million - $1.13 Million	-6,942 Reduced 2.54%	266,442 $42.1 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $10,192 - $11,121	70 Added 0.03%	273,384 $42.9 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $766,134 - $858,267	-4,919 Reduced 1.77%	273,314 $42.6 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $308,236 - $331,721	-1,997 Reduced 0.71%	278,233 $46.1 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $717,789 - $856,595	-4,752 Reduced 1.67%	280,230 $43.4 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $544,199 - $610,746	-3,397 Reduced 1.18%	284,982 $50.3 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $571,269 - $635,680	-3,541 Reduced 1.21%	288,379 $47.1 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $356,730 - $394,527	-2,121 Reduced 0.72%	291,920 $51.8 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $1.65 Million - $1.88 Million	-10,463 Reduced 3.44%	294,041 $52.1 Million
Q4 2021 Jan 28, 2022	SELL	$155.93 - $173.01 $1.18 Million - $1.3 Million	-7,539 Reduced 2.42%	304,504 $52.1 Million
Q3 2021 Nov 04, 2021	BUY	$161.5 - $179.47 $287,308 - $319,277	1,779 Added 0.57%	312,043 $50.4 Million
Q2 2021 Jul 28, 2021	BUY	$159.48 - $171.07 $3.07 Million - $3.29 Million	19,243 Added 6.61%	310,264 $51.1 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $4.46 Million - $4.97 Million	-29,160 Reduced 9.11%	291,021 $47.8 Million
Q4 2020 Feb 10, 2021	SELL	$137.11 - $157.38 $1.9 Million - $2.18 Million	-13,882 Reduced 4.16%	320,181 $50.4 Million
Q3 2020 Nov 02, 2020	SELL	$140.38 - $153.83 $433,774 - $475,334	-3,090 Reduced 0.92%	334,063 $49.7 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $313,652 - $378,666	-2,435 Reduced 0.72%	337,153 $47.4 Million
Q1 2020 May 05, 2020	SELL	$111.14 - $153.99 $936,243 - $1.3 Million	-8,424 Reduced 2.42%	339,588 $44.5 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $1.06 Million - $1.22 Million	-8,340 Reduced 2.34%	348,012 $50.8 Million
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $1.15 Million - $1.29 Million	-9,085 Reduced 2.49%	356,352 $46.1 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $578,633 - $636,386	-4,412 Reduced 1.19%	365,437 $50.9 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $737,222 - $819,728	-5,864 Reduced 1.56%	369,849 $51.7 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $1.89 Million - $2.28 Million	-15,407 Reduced 3.94%	375,713 $48.5 Million
Q3 2018 Oct 29, 2018	SELL	$121.58 - $142.88 $1.73 Million - $2.04 Million	-14,253 Reduced 3.52%	391,120 $54 Million
Q2 2018 Jul 25, 2018	SELL	$119.4 - $131.76 $1.44 Million - $1.59 Million	-12,070 Reduced 2.89%	405,373 $0
Q1 2018 Apr 25, 2018	SELL	$125.1 - $148.14 $1.55 Million - $1.83 Million	-12,383 Reduced 2.88%	417,443 $0
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $4.67 Million - $5.11 Million	-35,565 Reduced 7.64%	429,826 $0
Q3 2017 Oct 27, 2017	BUY	$129.47 - $135.38 $60.3 Million - $63 Million	465,391	465,391 $0

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.

Account

Beck Mack & Oliver LLC Johnson & Johnson Transaction History